Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

rrCLL × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13011 Neoplasms 10392 Carcinoma, Non-Small-Cell Lung 6808 Prostatic Neoplasms 6205 Colorectal Neoplasms 5873 Lung Neoplasms 5047 Multiple Myeloma 3545 Pancreatic Neoplasms 3516 Neoplasm Metastasis 3482 Leukemia, Myeloid, Acute 3471 Carcinoma, Hepatocellular 3235 Ovarian Neoplasms 3144 Melanoma 3120 Stomach Neoplasms 3024 Lymphoma 2971 Head and Neck Neoplasms 2576 Recurrence 2532 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2486 Leukemia 2354 Colonic Neoplasms 2320 Brain Neoplasms 2296 Lymphoma, Non-Hodgkin 2259 Rectal Neoplasms 2174 Uterine Cervical Neoplasms 2168 Glioblastoma 1997 Leukemia, Lymphocytic, Chronic, B-Cell 1985 Carcinoma, Renal Cell 1898 Squamous Cell Carcinoma of Head and Neck 1859 Lymphoma, Follicular 1831 Esophageal Neoplasms 1785

Interventions

pembrolizumab 1 dinaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02684617 2021-03-01

KEYNOTE-155

Merck Sharp & Dohme LLC

Phase 1 Terminated

75 enrolled 17 charts

rrCLL

Data powered by HemOnc (CC BY 4.0) Colophon ⚡